News
LTRN
2.810
-1.75%
-0.050
Weekly Report: what happened at LTRN last week (0803-0807)?
Weekly Report · 1d ago
New to The Street Show 766 Broadcasts Tonight at 6:30 PM ET on Bloomberg Television, Featuring BioVie's Bezisterim Parkinson's Disease Clinical Results
Barchart · 3d ago
Press Release: Lantern Pharma to Report Second Quarter 2026 Operating & Financial Results on August 14th, 2026 at 9:00 a.m. ET
Dow Jones · 4d ago
Lantern Pharma Spins Off Open-Medicine AI Platform
TipRanks · 08/03 22:18
Lantern Pharma establishes Open-Medicine AI as separate company
TipRanks · 08/03 11:36
Lantern Pharma Creates Open-Medicine AI As Separate Entity
Benzinga · 08/03 11:34
Weekly Report: what happened at LTRN last week (0727-0731)?
Weekly Report · 08/03 09:14
New to The Street TV Announces Broadcast of Show No. 765 Tonight on Bloomberg Television at 6:30 PM ET Featuring Envoy Medical, Graphene Manufacturing Group, Rhino Bitcoin, and Big Sky Industrial
Barchart · 08/01 10:30
Lantern Pharma to advance EMA-cleared Phase 1b/2 trial of LP-184
TipRanks · 07/28 11:50
Lantern Pharma Announces EMA Clearance Of An Investigator-Initiated Phase 1b/2 Clinical Trial Of LP-184 In Advanced, Recurrent Bladder Cancer
Benzinga · 07/28 11:47
Weekly Report: what happened at LTRN last week (0720-0724)?
Weekly Report · 07/27 09:15
New to The Street to Broadcast Nationwide on Bloomberg Television Tonight at 6:30 PM ET Featuring RHINO Bitcoin, Marina Decisions, Medicus Pharma and Virtuix Holdings
Barchart · 07/25 12:10
Lantern Pharma Receives Notice Of Allowance From U.S. Patent And Trademark Office For 'Methods For The Treatment Of Solid Tumor Cancers Using Illudins And Biomarkers'
Benzinga · 07/23 12:09
Lantern Pharma receives USPTO notice of allowance for patent of LP-184
TipRanks · 07/23 12:05
Weekly Report: what happened at LTRN last week (0713-0717)?
Weekly Report · 07/20 09:14
New to The Street(R) to Broadcast Show #762 Tonight on Bloomberg Television at 6:30 PM ET, Featuring Envoy Medical (NASDAQ:COCH), AlphaCompute (NASDAQ:ALP), RHINO Bitcoin (OTC PINK:RHNO), and Big Sky Industrial (NASDAQ:BSIN)
Barchart · 07/18 11:40
Weekly Report: what happened at LTRN last week (0706-0710)?
Weekly Report · 07/13 09:15
New to The Street Show #761 to Broadcast Across Bloomberg U.S., Latin America and MENA, Featuring Sagtec Global, Virtuix, Lantern Pharma and YY Group
Barchart · 07/11 11:30
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 07/08 17:05
Lantern Pharma launches ZetaOmics computational-biology module
TipRanks · 07/08 11:35
More
Webull provides a variety of real-time LTRN stock news. You can receive the latest news about Lantern Pharma Inc through multiple platforms. This information may help you make smarter investment decisions.
About LTRN
Lantern Pharma Inc. is an artificial intelligence (AI) company. The Company is developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, leverages over 200 billion oncology-focused data points and a library of 200+ ML algorithms. It is engaged in the development of its pipeline of drug candidates that span multiple cancer indications, including both solid tumors and blood cancers and an antibody drug conjugate program. Its portfolio includes a Phase II clinical program (LP-300) in NSCLC focused on never-smokers and non-smokers with the EGFR exon 21 L858R mutation; planned Phase I b/II trials (LP-184) in precision, biomarker-defined solid tumors, and an ongoing Phase II program in hematologic malignancies and adult soft tissue sarcomas (LP-284). It is also focused on the clinical execution of its therapies for CNS and brain cancers through Starlight Therapeutics Inc.